Eargo 5 vs Otofonix Groove

The Eargo 5 is a premium-priced OTC hearing aid ($1,450) featuring an invisible-in-ear design with rechargeable batteries. In our lab testing, it earned a B grade with a SoundScore of 3.6/5, placing it in the top 52% of the OTC hearing aid category. This device demonstrates solid performance for speech understanding in quiet environments, scoring 3.5/5—0.75 points above the category average of 2.79/5. Own-voice comfort also measures above average at 2.8/5 (+0.29 vs category), though this remains mixed in absolute terms. Feedback handling is strong at 4.2/5, providing reliable stability during wear. However, the Eargo 5 shows notable limitations in other areas. Speech in noise performance is low at 1.4/5, slightly below the category average. Most significantly, music streaming scored 0.0/5, falling 1.92 points below the category average—this device does not support audio streaming functionality. The invisible-in-ear form factor appeals to users prioritizing discretion, and the closed sleeve coupling remains consistent between initial and tuned fits. Tuning provided modest improvement, moving from a normalized Initial Score of 3.5/5 to a Tuned Score of 3.7/5. Given its premium price point, consumers may want to compare against alternatives like the Sony CRE-C10 or Nuance Audio Glasses, which offer similar or better sound performance at lower price points. The Eargo 5 is best suited for users who prioritize cosmetic discretion and primarily need help with speech in quieter settings.

The Otofonix Groove is a behind-the-ear prescription hearing aid priced at $795, earning a C grade with a SoundScore of 2.7/5 in our lab testing. This rechargeable BTE ranks #38 of 39 devices in the prescription hearing aid category, placing it in the bottom 5% of its class. In our testing, the Groove demonstrated excellent feedback handling at 5.0/5, scoring 0.28 points above the category average. This represents a genuine strength, with the device maintaining stability during our standardized challenge motions. However, speech performance was significantly limited, with speech in quiet scoring 1.0/5 (2.40 points below the category average of 3.40) and speech in noise also at 1.0/5 (1.11 points below average). Music streaming was not functional in our tests, scoring 0.0/5 against a category average of 2.76. Own-voice comfort also fell well below typical prescription hearing aid performance at 0.4/5, which is 2.30 points below the category average. At this price point, several lower-cost alternatives delivered stronger overall performance in our testing. Consumers seeking value in the prescription category may want to explore other options, though those requiring robust feedback control in a rechargeable BTE format may find the Groove's stability noteworthy despite its other limitations.